Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference

被引：475
作者：
Goodship, Timothy H. J. [1 ]
Cook, H. Terence [2 ]
Fakhouri, Fadi [3 ,4 ]
Fervenza, Fernando C. [5 ]
Fremeaux-Bacchi, Veronique [6 ]
Kavanagh, David [1 ]
Nester, Carla M. [7 ,8 ]
Noris, Marina [9 ]
Pickering, Matthew C. [2 ]
de Cordoba, Santiago Rodriguez [10 ,11 ]
Roumenina, Lubka T. [12 ,13 ,14 ]
Sethi, Sanjeev [15 ]
Smith, Richard J. H. [7 ,8 ]
机构：
[1] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England
[2] Ctr Complement & Inflammat Res, Dept Med, Imperial Coll Hammersmith Campus, London, England
[3] CHU Nantes, INSERM, UMR S 1064, Nantes, France
[4] CHU Nantes, Dept Nephrol & Immunol, Nantes, France
[5] Mayo Clin, Dept Hypertens & Nephrol, Rochester, MN USA
[6] Hop Europeen Georges Pompidou, AP HP, Paris, France
[7] Univ Iowa, Carver Coll Med, Mol Otolaryngol & Renal Res Labs, Iowa City, IA USA
[8] Univ Iowa, Carver Coll Med, Dept Internal Med, Div Nephrol, Iowa City, IA USA
[9] IRCCS, Ist Ric Farmacol Mario Negri, Clin Res Ctr Rare Dis Aldo & Cele Dacco Ranica, Bergamo, Italy
[10] CSIC, Ctr Invest Biol, Madrid, Spain
[11] Ctr Invest Biomed Enfermedades Raras, Madrid, Spain
[12] Inst Natl Sante & Rech Med, Ctr Rech Cordeliers, Unite Mixte Rech 51138, Complement & Malad, Paris, France
[13] Univ Paris 05, Sorbonne Paris Cite, Paris, France
[14] UPMC Paris 6, Paris, France
[15] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
来源：
KIDNEY INTERNATIONAL | 2017年 / 91卷 / 03期
基金：
英国惠康基金; 英国医学研究理事会;
关键词：
anti-complement therapies; atypical hemolytic uremic syndrome; C3; glomerulopathy; complement; glomerulonephritis; kidney disease; COMPLEMENT FACTOR-H; DENSE-DEPOSIT DISEASE; ECULIZUMAB MAINTENANCE TREATMENT; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIOCAPILLARY GLOMERULONEPHRITIS; RENAL-TRANSPLANTATION; OXFORD CLASSIFICATION; MACULAR DEGENERATION; ALTERNATIVE PATHWAY; CLINICAL-FEATURES;
D O I：
10.1016/j.kint.2016.10.005
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G) complement plays a primary role in disease pathogenesis. Herein we report the outcome of a 2015 Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference where key issues in the management of these 2 diseases were considered by a global panel of experts. Areas addressed included renal pathology, clinical phenotype and assessment, genetic drivers of disease, acquired drivers of disease, and treatment strategies. In order to help guide clinicians who are caring for such patients, recommendations for best treatment strategies were discussed at length, providing the evidence base underpinning current treatment options. Knowledge gaps were identified and a prioritized research agenda was proposed to resolve outstanding controversial issues.
引用
收藏
页码：539 / 551
页数：13
相关论文
共 114 条
  • [11] Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome
    Bernabeu-Herrero, Maria E.
    Jimenez-Alcazar, Miguel
    Anter, Jaouad
    Pinto, Sheila
    Sanchez Chinchilla, Daniel
    Garrido, Sofia
    Lopez-Trascasa, Margarita
    Rodriguez de Cordoba, Santiago
    Sanchez-Corral, Pilar
    [J]. MOLECULAR IMMUNOLOGY, 2015, 67 (02) : 276 - 286
  • [12] A novel CFHR5 mutation associated with C3 glomerulonephritis in a Turkish girl
    Besbas, Nesrin
    Gulhan, Bora
    Gucer, Safak
    Korkmaz, Emine
    Ozaltin, Fatih
    [J]. JOURNAL OF NEPHROLOGY, 2014, 27 (04) : 457 - 460
  • [13] Eculizumab for Dense Deposit Disease and C3 Glomerulonephritis
    Bomback, Andrew S.
    Smith, Richard J.
    Barile, Gaetano R.
    Zhang, Yuzhou
    Heher, Eliot C.
    Herlitz, Leal
    Stokes, M. Barry
    Markowitz, Glen S.
    D'Agati, Vivette D.
    Canetta, Pietro A.
    Radhakrishnan, Jai
    Appel, Gerald B.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (05): : 748 - 756
  • [14] Bonucchi Decenzio, 2010, G Ital Nefrol, V27 Suppl 52, pS82
  • [15] Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype
    Bresin, Elena
    Rurali, Erica
    Caprioli, Jessica
    Sanchez-Corral, Pilar
    Fremeaux-Bacchi, Veronique
    Rodriguez de Cordoba, Santiago
    Pinto, Sheila
    Goodship, Timothy H. J.
    Alberti, Marta
    Ribes, David
    Valoti, Elisabetta
    Remuzzi, Giuseppe
    Noris, Marina
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (03): : 475 - 486
  • [16] High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies
    Bu, Fengxiao
    Borsa, Nicolo Ghiringhelli
    Jones, Michael B.
    Takanami, Erika
    Nishimura, Carla
    Hauer, Jill J.
    Azaiez, Hela
    Black-Ziegelbein, Elizabeth A.
    Meyer, Nicole C.
    Kolbe, Diana L.
    Li, Yingyue
    Frees, Kathy
    Schnieders, Michael J.
    Thomas, Christie
    Nester, Carla
    Smith, Richard J. H.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (04): : 1245 - 1253
  • [17] Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease
    Caprioli, J
    Castelletti, F
    Bucchioni, S
    Bettinaglio, P
    Bresin, E
    Pianetti, G
    Gamba, S
    Brioschi, S
    Daina, E
    Remuzzi, G
    Noris, M
    [J]. HUMAN MOLECULAR GENETICS, 2003, 12 (24) : 3385 - 3395
  • [18] Genetics of HUS:: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
    Caprioli, Jessica
    Noris, Marina
    Brioschi, Simona
    Pianetti, Gaia
    Castelletti, Federica
    Bettinaglio, Paola
    Mele, Caterina
    Bresin, Elena
    Cassis, Linda
    Gamba, Sara
    Porrati, Francesca
    Bucchioni, Sara
    Monteferrante, Giuseppe
    Fang, Celia J.
    Liszewski, M. K.
    Kavanagh, David
    Atkinson, John P.
    Remuzzi, Giuseppe
    [J]. BLOOD, 2006, 108 (04) : 1267 - 1279
  • [19] The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
    Cattran, Daniel C.
    Coppo, Rosanna
    Cook, H. Terence
    Feehally, John
    Roberts, Ian S. D.
    Troyanov, Stephan
    Alpers, Charles E.
    Amore, Alessandro
    Barratt, Jonathan
    Berthoux, Francois
    Bonsib, Stephen
    Bruijn, Jan A.
    D'Agati, Vivette
    D'Amico, Giuseppe
    Emancipator, Steven
    Emma, Francesco
    Ferrario, Franco
    Fervenza, Fernando C.
    Florquin, Sandrine
    Fogo, Agnes
    Geddes, Colin C.
    Groene, Hermann-Josef
    Haas, Mark
    Herzenberg, Andrew M.
    Hill, Prue A.
    Hogg, Ronald J.
    Hsu, Stephen I.
    Jennette, J. Charles
    Joh, Kensuke
    Julian, Bruce A.
    Kawamura, Tetsuya
    Lai, Fernand M.
    Leung, Chi Bon
    Li, Lei-Shi
    Li, Philip K. T.
    Liu, Zhi-Hong
    Mackinnon, Bruce
    Mezzano, Sergio
    Schena, F. Paolo
    Tomino, Yasuhiko
    Walker, Patrick D.
    Wang, Haiyan
    Weening, Jan J.
    Yoshikawa, Nori
    Zhang, Hong
    [J]. KIDNEY INTERNATIONAL, 2009, 76 (05) : 534 - 545
  • [20] A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic Syndrome
    Challis, Rachel C.
    Araujo, Geisilaine S. R.
    Wong, Edwin K. S.
    Anderson, Holly E.
    Awan, Atif
    Dorman, Anthony M.
    Waldron, Mary
    Wilson, Valerie
    Brocklebank, Vicky
    Strain, Lisa
    Morgan, B. Paul
    Harris, Claire L.
    Marchbank, Kevin J.
    Goodship, Timothy H. J.
    Kavanagh, David
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (06): : 1617 - 1624
12345678910